Cargando…

S255: CELLULAR SENESCENCE AND INFLAMMATORY PROGRAMS ARE UNINTENDED CONSEQUENCES OF CRISPR-CAS9 GENE EDITING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS

Detalles Bibliográficos
Autores principales:	Conti, Anastasia, Tavella, Teresa, De Marco, Rosaria, Midena, Federico, Ferrari, Samuele, Beretta, Stefano, Brombin, Chiara, Merelli, Ivan, Naldini, Luigi, DI Micco, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428406/ http://dx.doi.org/10.1097/01.HS9.0000967932.79281.37

Ejemplares similares

Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
por: Schiroli, Giulia, et al.
Publicado: (2019)

P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS
por: Fiumara, Martina, et al.
Publicado: (2023)

Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
por: Ferrari, Samuele, et al.
Publicado: (2020)

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
por: Ferrari, Samuele, et al.
Publicado: (2022)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs
por: Crippa, Stefania, et al.
Publicado: (2022)

S250: UNVEILING THE BIOLOGICAL ROLE OF PERIPHERAL BLOOD HUMAN CIRCULATING HEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Quaranta, Pamela, et al.
Publicado: (2023)

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
por: Vavassori, Valentina, et al.
Publicado: (2023)

Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis
por: Biavasco, Riccardo, et al.
Publicado: (2021)

Detection of unintended on-target effects in CRISPR genome editing by DNA donors carrying diagnostic substitutions
por: Lackner, Martin, et al.
Publicado: (2023)

P429: THERAPY-INDUCED SENESCENCE TRIGGERS UPREGULATION OF ANTIGEN PRESENTATION VIA PRC2 INHIBITION AND PROMOTES ANTI-TUMOUR IMMUNITY IN ACUTE MYELOID LEUKAEMIA
por: Gilioli, Diego, et al.
Publicado: (2023)

Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cells
por: Hunt, John Murray Topp, et al.
Publicado: (2023)

THE UNINTENDED CONSEQUENCES OF SEAMLESS IMPLEMENTATION OF A RURAL TELEMEDICINE CLINIC
por: Solimeo, Samantha, et al.
Publicado: (2019)

Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing
por: Park, So Hyun, et al.
Publicado: (2022)

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells
por: Omer-Javed, Attya, et al.
Publicado: (2022)

PRE-REGISTERING QUALITATIVE RESEARCH: BENEFITS, UNINTENDED CONSEQUENCES, AND UNANSWERED QUESTIONS
por: Bowers, Barbara
Publicado: (2019)

INS, OUTS, AND UNINTENDED CONSEQUENCES OF THE CMS NURSING HOME QUALITY MEASURES
por: Davila, Heather, et al.
Publicado: (2019)

p53 activation: a checkpoint for precision genome editing?
por: Conti, Anastasia, et al.
Publicado: (2018)

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome
por: Vavassori, Valentina, et al.
Publicado: (2021)

S271: AN UPDATED FOLLOW-UP OF BRL-101, CRISPR-CAS9-MEDIATED GENE EDITING OF THE BCL11A ENHANCER FOR TRANSFUSION-DEPENDENT BETA-THALASSE
por: Fu, Bin, et al.
Publicado: (2023)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Dussiau, Charles, et al.
Publicado: (2023)

Precise CRISPR-Cas–mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells
por: Tran, Ngoc Tung, et al.
Publicado: (2022)

An early‐senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro‐inflammatory program
por: Gnani, Daniela, et al.
Publicado: (2019)

Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients
por: Marcovecchio, Genni Enza, et al.
Publicado: (2021)

Methylome of human senescent hematopoietic progenitors
por: Capone, Stephen, et al.
Publicado: (2018)

Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients
por: Diez, Begoña, et al.
Publicado: (2017)

Oak Ridge: 25.5 megavolts
Publicado: (1989)

Oak Ridge : 25,5 mégavolts
Publicado: (1989)

Health Tract, No. 255: Early Rising
Publicado: (1866)

Infection and immunity in farm animals: Edited by R. Pandey Basel: S. Karger. 1985. 255 pp. SFr. 164
por: Rutter, J.M.
Publicado: (1986)

Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
por: Cromer, M. Kyle, et al.
Publicado: (2022)

Targeted Genome Editing in Human Repopulating Hematopoietic Stem Cells
por: Genovese, Pietro, et al.
Publicado: (2014)

HETEROGENEITY OF SENESCENT RIBOSOME COMPLEX AFFECTS THE TRANSLATIONAL EFFICIENCY OF SENESCENCE RELATED MRNAS
por: Kim, Joon, et al.
Publicado: (2019)

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia
por: Rocca, Celine J., et al.
Publicado: (2020)

Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration
por: Bloomer, Hanan, et al.
Publicado: (2021)

BIOMARKERS OF SENESCENT CELL BURDEN
por: LeBrasseur, Nathan
Publicado: (2019)

Irradiation of the TC255P CCD by Fast Neutrons
por: Hashemi, K S, et al.
Publicado: (1998)

I. Verzeichnis der in Band 255 enthaltenen Arbeiten
Publicado: (1983)

S252: MODULATING HEMATOPOIESIS: ENGINEERING TPO VARIANTS WITH DISTINCT HEMATOPOIETIC FUNCTION
por: Masoumi, Zahra, et al.
Publicado: (2023)

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
por: Ferrari, Samuele, et al.
Publicado: (2021)

Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells
por: Yudovich, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qh4q8rkcqd6hdh4q75shimgudp